ERBB2 and gastric cancer: The Trastuzumab for Gastric Cancer (ToGA) study clarified that proper detection and evaluation of HER2 protein expression and gene amplification status of gastric cancer are of great significance for the clinical diagnosis and treatment of gastric cancer (Bang et al., 2010).